A review of methods available for the identification of both organ-specific and non-organ-specific autoantibodies

Annals of Clinical Biochemistry

Volumn 35, Issue 1, 1998, Pages 19-47

  Miles, Judith ^a   Charles, Peter ^b   Riches, Pamela ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Agglutination; Autoimmune diseases; ELISA; Indirect immunofluorescence; Standardization

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; INTRINSIC FACTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY; PARIETAL CELL ANTIBODY; RHEUMATOID FACTOR; SPERM ANTIBODY; THYROID ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE COST; HUMAN; IMMUNOFLUORESCENCE; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION;

EID: 0031973182     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329803500104     Document Type: Article

References (86)

1. Heidelberger M, Kendall FE. The precipitin reaction between type III pneumococcus polysaccharide and homologous antibody. J Exp Med 1935; 61: 563-91
2. Holborow EJ, Johnson GD. Standardisation in immunofluorescence. Ann NY Acad Sci 1983; 420: 62-4
3. Hughes-Jones NC. Antigens, antibodies, and antigen antibody reaction concerning the human red cell. In: D Selgson, ed. Blood Banking. Section D: CRC Handbook Series in Clinical Laboratory Science. Cleveland: CRC Press, 1977: 493-7
4. Singer JM, Plotz CM. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med 1956; 21: 288-92
5. Wilkins TA, Brouwers G, Mareschal JC, Cambasio CL. High sensitivity, homogeneous particle based immunoassay for thyrotropin. Clin Chem 1988; 34: 1749-52
6. Tatlor RN. Measurement of variation and significance in serologic tests. Ann NY Acad Sci 1983; 420: 13-21
7. Leedman PJ, Harrison PJ, Harrison LC. Immunoblotting for the detection of TSH receptor autoantibodies. J Autoimmune 1991; 4: 529-42
8. Ludgate M, Perret J, Parmentier M, Gerard C, Libert F, Dumont JE, et al. Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies. Mol Cell Endocrinol 1990; 73: R13-18
9. Filetti S, Foti D, Costante G, Rapoport B. Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor antibodies. J Clin Endocrinol Metab 1991; 72: 1096-101
10. Vitti P, Rotella CM, Valente WA, Cohen J, Aloj SM, Laccetti P, et al. Characterisation of the optimal stimulatory effects of Graves' monoclonal and serum immunoglobulin G on adenosine 3′, 5′-monophosphate production in FRTL5 thyroid cells: a potential clinical assay. J Clin Endocrinol Metab 1983; 57: 782-91
11. Nordyke RA, Gilbert FI, Miyamoto LA, Fleury KA. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med 1993; 153: 862-5
12. Haubruck H, Mauch L, Cook NJ, Steffens U, Hunt N, Berthold H, et al. Expression of recombinant thyroid peroxidase by the baculovirus system and its use in ELISA screening for diagnosis of autoimmune thyroid disease. Autoimmunity 1993; 15: 275-84
13. Milford Ward A, White PAE, Dangerfield VJM, Finch SG. Evaluation of seven commercial kits for the detection of thyroglobulin and thyroid microsomal antibodies. DH Autoimmune Serology Kit Evaluation Unit July 1989; STD/89/30
14. Bronson R, Cooper G, Rosenfeld D. Sperm antibodies: their role in infertility. Fertil Steril 1984; 42: 171-83
15. Tung K. Immunologic basis of male infertility [Editorial]. Lab Invest 1987; 57: 1-4
16. Meinertz H, Hjort T. Detection of autoimmunity to sperm: mixed antiglobulin reaction (MAR) test or sperm agglutination? A study on 537 men from infertile couples. Fertil Steril 1986; 46: 86-91
17. Lynch DM, Leali BA, Howe SE. A comparison of sperm agglutination and immobilization assays with a quantitative ELISA for anti-sperm antibody in serum. Fertil Steril 1986; 46: 285-92
18. Saji F, Negoro T, Ohashi K, Tanizawa O, Kato M. Clinical evaluation of the enzyme-linked immunosorbent assay (ELISA) kit for antisperm antibodies. Fertil Steril 1988; 50: 644-7
19. Vandelli C, Bottazzo GF, Franceschi F. Autoantibodies to gastrin-producing cells in antral (type B) chronic gastritis. N Engl J Med 1979; 300: 1406-10
20. Cummins D, Ardeman S. Intrinsic factor antibodies and pernicious anaemia. Lancet 1991; 338: 383-4
21. Gleeson PA, Toh BH. Molecular targets in pernicious anaemia. Immunol Today 1991; 12: 233-8
22. Hawkins BR, McDonald BL, Dawkins RL. Characterization of immunofluorescent heterophile antibodies which may be confused with autoantibodies. J Clin Pathol 1997; 30: 299-307
23. Samloff IM, Kleinman MS, Turner MD, Sobel MV, Jeffries GH. Blocking and binding antibodies to intrinsic factor and parietal cell antibody in pernicious anaemia. Gastroenterology 1968; 55: 575-83
24. 12 binding capacity. Blood 1965; 25: 875-83
25. Calabuig M, Torregosa R, Polo P, Tuset L, Tomas C, Alvarez V et al. Serological markers and celiac disease: a new diagnostic approach? J Pediatr Gastroenterol Nutr 1990; 10: 435-42
26. Unsworth DJ, Walker-Smith JA, Holborow EJ. Gliadin and reticulin antibodies in childhood coeliac disease. Lancet 1983; 1(8329): 874-5
27. Mawhinney H, Tomkin GH. Gluten enteropathy associated with selective IgA deficiency. Lancet 1971; 716: 121-4
28. Hakeem V, Fifield R, al-Bayaty HF, Aldred MJ, Walker DM, Williams J, et al. Salivary IgA antigliadin antibody as a marker for coeliac disease. Archiv Dis Child 1992; 67: 724-7
29. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776-8
30. Rizzetto M, Doniach D. Types of 'reticulin' antibodies detected in human sera by immunofluorescence. J Clin Pathol 1973; 26: 841-51
31. Bylund DJ, McHutchinson J, Nakamura RM. Antimitochondrial antibodies in primary biliary cirrhosis. Clin Immunol Newsletter 1992; 12: 1-5
32. Kenny RP, Czaja AJ, Ludwig, J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 1986; 31: 705-11
33. Berg PA, Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance [published erratum appears in Dig Dis 1992; 10: 248] Dig Dis 1992; 10: 85-101
34. Lidman K. Clinical diagnosis in patients with smooth muscle antibodies. A study of a one-year material. Acta Med Scand 1976; 200: 403-7
35. Bretherton L, Brown C, Pederson JS, Toh BH, Clarke FM, Mackay IR, et al. ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 1983; 51: 611-6
36. Homberg J-C, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with antiliver kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987; 7: 1333-9
37. Homberg J-C, Andre C, Abuaf N. A new antiliver kidney microsomal antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol 1984; 55: 561-70
38. Philipp T, Durazzo M, Trautwein C, Alex B, Straub P, Lamb JG, et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Comment in Lancet 1994; 344: 560-1 & Lancet 1994; 344: 1369-70
39. Philipp T, Durazzo M, Trautwein C, Alex B, Straub P, Lamb JG, et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Comment in Lancet 1994; 344: 560-1 & Lancet 1994; 344: 1369-70
40. Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, et al. Heterogeneity of liver/ kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 1995; 37: 406-12
41. Beutner EH, Chorzelski TP, Jablonska S. Immunofluorescence tests: Clinical significance of sera and skin in bullous diseases. Int J Dermatol 1985; 24: 405-21
42. Stanley JR. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest 1989; 83: 1443-8
43. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley JR. Autoantibodies against the aminoterminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90: 919-26
44. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common noncollagenous site on the BP180 ectodomain. J Immunol 1993; 151: 5742-50
45. Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978; 28: 266-72
46. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054-59
47. Somnier FE. Antiacetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen. J Neuroimmunol 1994; 51: 63-8
48. Bonifacio E, Cobain TJ, Dawkins RL, Griffiths M, Kalden JR, Peter JB, et al. Comparison and standardisation of measurement of anti-acetylcholine receptor antibody between laboratories. Autoimmunity 1988; 1: 59-66
49. Carrano JA, Swanson NR, Dawkins RL. An enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: comparison with indirect immunofluorescence. J Immunol Meth 1983; 59: 301-14
50. Li Z, Forester N, Vincent A. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis. J Neuroimmunol 1996; 64: 179-83
51. Weller M, Stevens A, Sommer N, Dichgans J, Kappler B, Wietholter H. Ganglioside antibodies: a lack of diagnostic specificity and clinical utility? J Neurol 1992; 239: 455-9
52. Sher E, Gotti C, Canal N, Scoppetta C, Piccolo G, Evoli A, et al. Specificity of calcium channel autoantibodies in Lambert Eaton myasthenic syndrome. Lancet 1989; ii: 640-3
53. Wieslander J, Barr JF, Butkowski RJ, Edwards SJ, Bygren P, Heinegard D, et al. Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA 1984; 81: 3838-42
54. McPhaul JJ, Dixon FJ. Characterisation of human anti-glomerular basement membrane antibodies eluted from glomerulonephritic kidneys. J Clin Invest 1970; 49: 308-17
55. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987; i: 1389-93
56. Egner W, Chapel HM. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 1990; 82: 244-9
57. Anonymous. Anti neutrophil cytoplasm antibodies. Proceedings of the 1st International Workshop on ANCA. Copenhagen, 1988. Apmis Suppl 1989; 6: 1-49
58. Ludeman J, Utect B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990; 171: 357-62
59. Falk RJ, Jennette CJ. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-7
60. Owinata AA, Peter JB, Agopian M, Rittenhouse J, Liu Y, Barka N. Use of flow cytometry for quantification of anti-neutrophil cytoplasmic antibodies. Sixth Annual Meeting of Clinical Application of Cytometry, South Carolina, September 1991
61. Jayne DRW, Marshall PD, Jones SL, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990; 37: 965-70
62. Lock RJ. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol 1994; 47: 4-8
63. Natvig JB, Gaarder PI, Turner MW. IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol 1972; 12: 177-84
64. Jonsson T, Valdimarsson H. Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 1993; 52: 161-4
65. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep corpuscles. Acta Pathol Microbiol Scand 1940; 1: 172-88
66. Rose HM, Ragan C, Pearce E, Lipman MO. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 1949; 68: 1-6
67. Friou GJ. The early days of the antinuclear antibody story: where and how did it all start? Ann Med Interne (Paris) 1993; 144: 154-6
68. Humbel RL and Kadusch P. Use of HEp-2 cells in the IF test for detection of antinuclear antibodies. Protides of the biological fluids. In: Peeters H, ed. Proceedings 35th Colloquium, Vol. 33. Oxford: Pergamon Press, 1985: 385-7
69. Feltkamp TEW, Klein F, Janssens MBJA. Standardisation of the quantitative determination of antinuclear antibodies (ANA) with a homogeneous pattern. Ann Rheum Dis 1988; 47: 906-9
70. Hollingsworth PN, Bonifacio E, Dawkins RL. Use of a standard curve improves precision and concordance of antinuclear antibody measurement. J Clin Lab Immunol 1987; 22: 197-200
71. Homburger HA. Laboratory medicine and pathology: cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc 1995; 70: 183-4
72. Molden DP, Nakamura RM, Tan EM. Standardisation of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. Am J Clin Pathol 1984; 82: 57-66
73. Smeenk RJT. Measurement of antibodies to DNA. In: van Venrooij WJ, Maini RN, eds Manual of Biological Markers of Disease Vol. A8. Netherlands: Kleuwer, 1993: 1-12
74. Swaak T, Smeenk RJ. Detection of anti-dsDNA as a diagnosis tool: a prospective study in 441 nonsystemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985; 44: 245-51
75. Borg EJ, Horst G, Hummell EJ, Limburgh PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation on systemic lupus erythematosus, a long-term, prospective study. Arth Rheum 1990; 33: 634-43
76. Brinkman K, Termaat RM, van den Brink H, Berden J, Smeenk R. The specificity of the anti-dsDNA ELISA. A closer look. J Immunol Meth 1991; 139: 91-100
77. Bunn C, Kveder T. Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens. In: van Venrooij WJ, Maini RN, eds Manual of Biological Markers of Disease Vol. A3. Netherlands: Kleuwer, 1993: 1-12
78. Verheijen R, Salden M, van Venrooij WJ. Protein Blotting. In: van Venrooij WJ, Maini RN, eds Manual of Biological Markers of Disease, Vol. A4. Netherlands: Kleuwer, 1993: 1-25
79. Charles PJ, Maini RN. Enzyme-linked immunosorbent assay in the rheumatological laboratory. In: van Venrooij WJ, Maini RN, eds Manual of Biological Markers of Disease Vol. A.5. Netherlands: Kleuwer, 1993: 1-23
80. Venables PJW, Charles PJ, Buchannan RC, Tung Yi, Mumford PA, Maini RN. Quantification and detection of isotypes of anti-SSB antibodies by ELISA and Farr assays using affinity purified antigens. Arth Rheum 1982; 26: 146-55
81. Moroi Y, Peebles C, Fritler MJ, Steigerwald J, Tan EM. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980; 77: 1627-31
82. Weiner ES, Earnshaw WC, Snecal J, Bodwell B, Johnson P, Rothfield NF. Clinical associations of anticentromere antibodies and antibodies to topoisomerase 1. Arth Rheum 1988; 31: 378-85
83. 2-GP critical for lipid binding and anticardiolipin antibody cofactor. Proc Nat Acad Sci 1993; 90: 2141-5
84. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arth Rheum 1996; 39: 1444-54
85. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, Potron G, et al. Multicenter evaluation of nine commercial kits for the quantification of anticardiolipin antibodies. Thromb Haem 1995; 73: 444-52
86. Ward AM, White PAE. Measuring cardiolipin antibodies. Brit Med J 1995; 310: 1472-3